Synopsis
Synopsis
0
VMF
0
Europe
0
Australia
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. 4,4'-methylenebis(3-hydroxy-2-naphthoic Acid)-3-(10,11-dihydro-5h-dibenzo(b,f)azepin-5-yl)-n,n-dimethyl-1-propanamine (1:2)
2. Imidobenzyle
3. Imipramine
4. Imipramine Monohydrochloride
5. Imipramine Pamoate
6. Imizin
7. Janimine
8. Melipramine
9. Norchlorimipramine
10. Pryleugan
11. Tofranil
1. 113-52-0
2. Imipramine Hcl
3. Tofranil
4. Pryleugan
5. Imizine
6. Chimoreptin
7. Chrytemin
8. Presamine
9. Feinalmin
10. Imilanyle
11. Persamine
12. Pertofram
13. Teperine
14. Tofranile
15. Iprogen
16. Janimine
17. Pramine
18. Imp Hydrochloride
19. Ia-pram
20. Imizin
21. Co Cap Imipramine 25
22. Melipramine Hcl
23. Antideprin Hydrochloride
24. Imipramini Hydrochloridum
25. Imipramine Monohydrochloride
26. Imizinum
27. Imidol
28. Imipramine (hydrochloride)
29. G 22355
30. 3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-n,n-dimethylpropan-1-amine;hydrochloride
31. Nsc-114900
32. N-(3-dimethylaminopropyl)iminodibenzyl Hydrochloride
33. Bke5q1j60u
34. Mls000028430
35. Chebi:5882
36. Deprinol
37. 3-(10,11-dihydro-5h-dibenzo[b,f]azepin-5-yl)-n,n-dimethylpropan-1-amine Hydrochloride
38. 5-(3-(dimethylamino)propyl)-10,11-dihydro-5h-dibenz(b,f)azepine Monohydrochloride
39. 5h-dibenz(b,f)azepine-5-propanamine, 10,11-dihydro-n,n-dimethyl-, Monohydrochloride
40. Sk-pramine
41. Psicopramine
42. Thymopramin
43. Dynazina
44. Efuranol
45. Fujisawa
46. Imipramini
47. Odeoxil
48. Smr000058388
49. Tipramine
50. Venefon
51. Vionyl
52. Tofranil (tn)
53. 5h-dibenz[b,f]azepine-5-propanamine, 10,11-dihydro-n,n-dimethyl-, Monohydrochloride
54. G-22355
55. Imipram
56. Sk-pramine Hydrochloride
57. Imipramine Hydrochloride [jan]
58. Melipramine Hydrochloride
59. Sr-01000003064
60. Cas-113-52-0
61. Einecs 204-030-7
62. Mfcd00012669
63. Unii-bke5q1j60u
64. Nsc 114900
65. Imipraminehcl
66. Sk-pramine Hcl
67. Prestwick_277
68. Imipramine Hydrochloride [usp:jan]
69. Nebumetone Impurity D
70. N-(gamma-dimethylaminopropyl)iminodibenzyl Hydrochloride
71. 3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-n,n-dimethyl-propan-1-amine
72. Cpd000058388
73. Opera_id_319
74. N-(gamma-dimetilaminopropil)-iminodibenzile Cloridrato [italian]
75. Surecn41766
76. Imipramine Hydrochloride Rs
77. 5-(3-dimethylaminopropyl)-10,11-dihydro-5h-dibenz(b,f)azepine Hydrochloride
78. 5h-dibenz(b,f)azepine, 10,11-dihydro-5-(3-(dimethylamino)propyl)-, Hydrochloride
79. Chembl1692
80. Dsstox_cid_20738
81. Dsstox_rid_79581
82. Dsstox_gsid_40738
83. G 22150
84. Regid_for_cid_8228
85. Schembl41765
86. Mls001146891
87. Mls002222195
88. Spectrum1500348
89. N-(gamma-dimetilaminopropil)-iminodibenzile Cloridrato
90. Dtxsid7040738
91. Imipramine For System Suitability
92. Hms1568o05
93. Hms1920f17
94. Pharmakon1600-01500348
95. Hy-b1490
96. Tox21_301417
97. Tox21_500702
98. Ccg-40208
99. Imipramine Hydrochloride [mi]
100. Nsc114900
101. Nsc757074
102. S4377
103. Imipramine Hydrochloride (jp17/usp)
104. Akos015895330
105. Ac-7587
106. Cs-6180
107. Ks-1072
108. Lp00702
109. Nc00570
110. Nsc-757074
111. 5h-dibenz(b,f)azepine, 5-(3-(dimethylamino)propyl)-10,11-dihydro-, Monohydrochloride
112. Imipramine Hydrochloride [mart.]
113. Imipramine Hydrochloride [vandf]
114. Imipramine Hydrochloride [usp-rs]
115. Imipramine Hydrochloride [who-dd]
116. Imipramine Hydrochloride [who-ip]
117. Ncgc00024253-05
118. Ncgc00094054-01
119. Ncgc00094054-02
120. Ncgc00094054-03
121. Ncgc00094054-04
122. Ncgc00094054-05
123. Ncgc00255651-01
124. Ncgc00261387-01
125. (3-{2-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3,5,7,12,14-hexaen-2-yl}propyl)dimethylamine Hydrochloride
126. Bi164574
127. Imipramine Hydrochloride, >=99% (tlc)
128. Db-041172
129. Eu-0100702
130. Ft-0631652
131. Ft-0670318
132. I0971
133. St50985122
134. Sw196582-4
135. Imipramine Hydrochloride [orange Book]
136. C07982
137. D00815
138. I 7379
139. Imipramine Hydrochloride [ep Monograph]
140. Imipramine Hydrochloride [usp Impurity]
141. Imipramine Hydrochloride [usp Monograph]
142. Imipramini Hydrochloridum [who-ip Latin]
143. 113i520
144. Imipramine Hydrochloride, Bioxtra, >=99% (tlc)
145. Imipramine Hydrochloride, Sigma Reference Standard
146. J-002975
147. Lmipramine Hydrochloride 100 Microg/ml In Methanol
148. Q-200878
149. Sr-01000003064-2
150. Sr-01000003064-7
151. 5-(3-dimethylaminopropyl)-10,f)azepine Hydrochloride
152. Q27106923
153. Wln: T C676 Bn & T & J B3n1 & 1 & Gh
154. Z1551429721
155. N-(.gamma.-dimethylaminopropyl)iminodibenzyl Hydrochloride
156. 5h-dibenz[b, 10,11-dihydro-n,n-dimethyl-, Monohydrochloride
157. Imipramine Hydrochloride 1.0 Mg/ml In Methanol (as Free Base)
158. 5h-dibenz[b, 10,11-dihydro-5-[3-(dimethylamino)propyl]-, Hydrochloride
159. Imipramine Hydrochloride, European Pharmacopoeia (ep) Reference Standard
160. 10,11-dihydro-n,n-dimethyl-5h-dibenzo[b,f]azepine-5-propanamine Hydrochloride
161. 5-(3-dimethylaminopropyl)-10,11-dihydro-5h-dibenz-[b,f]-azepine, Hydrochloride
162. 5-[3-(dimethylamino)propyl]-10,11-dihydro-5h-dibenzo[b,f]azepine Hydrochloride
163. 5h-dibenz(b,f)azepine-5-propanamine, 10,11-dihydro-n,n-dimethyl-, Hydrochloride (1:1)
164. 5h-dibenz[b, 5-[3-(dimethylamino)propyl]-10,11-dihydro-, Monohydrochloride
165. Imipramine For System Suitability, European Pharmacopoeia (ep) Reference Standard
166. Imipramine Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
167. Imipramine Hydrochloride, United States Pharmacopeia (usp) Reference Standard
168. (3-{2-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl}propyl)dimethylamine Hydrochloride
169. Imipramine Hydrochloride Solution, 1.0 Mg/ml In Methanol (as Free Base), Ampule Of 1 Ml, Certified Reference Material
Molecular Weight | 316.9 g/mol |
---|---|
Molecular Formula | C19H25ClN2 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 4 |
Exact Mass | 316.1706265 g/mol |
Monoisotopic Mass | 316.1706265 g/mol |
Topological Polar Surface Area | 6.5 Ų |
Heavy Atom Count | 22 |
Formal Charge | 0 |
Complexity | 291 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 4 | |
---|---|
Drug Name | Imipramine hydrochloride |
PubMed Health | Imipramine (By mouth) |
Drug Classes | Antidepressant, Urinary Enuresis Agent |
Drug Label | Imipramine hydrochloride, the original tricyclic antidepressant, is a member of the dibenzazepine group of compounds. It is designated 5-[3-(Dimethylamino) propyl]-10, 11-dihydro-5H-dibenz [b,f]-azepine monohydrochloride. Structurally, it may be repr... |
Active Ingredient | Imipramine hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 25mg; 50mg; 10mg |
Market Status | Prescription |
Company | Excellium; Lupin; Sandoz; Par Pharm; Mutual Pharm |
2 of 4 | |
---|---|
Drug Name | Tofranil |
Drug Label | Tofranil is supplied in tablet form for oral administration.Tofranil, imipramine hydrochloride USP, the original tricyclic antidepressant, is a member of the dibenzazepine group of compounds. It is designated 5-3-(dimethylamino)propyl-10,11-dihydr... |
Active Ingredient | Imipramine hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 25mg; 50mg; 10mg |
Market Status | Prescription |
Company | Mallinckrodt |
3 of 4 | |
---|---|
Drug Name | Imipramine hydrochloride |
PubMed Health | Imipramine (By mouth) |
Drug Classes | Antidepressant, Urinary Enuresis Agent |
Drug Label | Imipramine hydrochloride, the original tricyclic antidepressant, is a member of the dibenzazepine group of compounds. It is designated 5-[3-(Dimethylamino) propyl]-10, 11-dihydro-5H-dibenz [b,f]-azepine monohydrochloride. Structurally, it may be repr... |
Active Ingredient | Imipramine hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 25mg; 50mg; 10mg |
Market Status | Prescription |
Company | Excellium; Lupin; Sandoz; Par Pharm; Mutual Pharm |
4 of 4 | |
---|---|
Drug Name | Tofranil |
Drug Label | Tofranil is supplied in tablet form for oral administration.Tofranil, imipramine hydrochloride USP, the original tricyclic antidepressant, is a member of the dibenzazepine group of compounds. It is designated 5-3-(dimethylamino)propyl-10,11-dihydr... |
Active Ingredient | Imipramine hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 25mg; 50mg; 10mg |
Market Status | Prescription |
Company | Mallinckrodt |
Adrenergic Uptake Inhibitors
Drugs that block the transport of adrenergic transmitters into axon terminals or into storage vesicles within terminals. The tricyclic antidepressants (ANTIDEPRESSIVE AGENTS, TRICYCLIC) and amphetamines are among the therapeutically important drugs that may act via inhibition of adrenergic transport. Many of these drugs also block transport of serotonin. (See all compounds classified as Adrenergic Uptake Inhibitors.)
Antidepressive Agents, Tricyclic
Substances that contain a fused three-ring moiety and are used in the treatment of depression. These drugs block the uptake of norepinephrine and serotonin into axon terminals and may block some subtypes of serotonin, adrenergic, and histamine receptors. However, the mechanism of their antidepressant effects is not clear because the therapeutic effects usually take weeks to develop and may reflect compensatory changes in the central nervous system. (See all compounds classified as Antidepressive Agents, Tricyclic.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Imipramine Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Imipramine Hydrochloride, including repackagers and relabelers. The FDA regulates Imipramine Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Imipramine Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Imipramine Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Imipramine Hydrochloride supplier is an individual or a company that provides Imipramine Hydrochloride active pharmaceutical ingredient (API) or Imipramine Hydrochloride finished formulations upon request. The Imipramine Hydrochloride suppliers may include Imipramine Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Imipramine Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Imipramine Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Imipramine Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Imipramine Hydrochloride DMFs exist exist since differing nations have different regulations, such as Imipramine Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Imipramine Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Imipramine Hydrochloride USDMF includes data on Imipramine Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Imipramine Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Imipramine Hydrochloride suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Imipramine Hydrochloride Drug Master File in Japan (Imipramine Hydrochloride JDMF) empowers Imipramine Hydrochloride API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Imipramine Hydrochloride JDMF during the approval evaluation for pharmaceutical products. At the time of Imipramine Hydrochloride JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Imipramine Hydrochloride suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Imipramine Hydrochloride Drug Master File in Korea (Imipramine Hydrochloride KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Imipramine Hydrochloride. The MFDS reviews the Imipramine Hydrochloride KDMF as part of the drug registration process and uses the information provided in the Imipramine Hydrochloride KDMF to evaluate the safety and efficacy of the drug.
After submitting a Imipramine Hydrochloride KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Imipramine Hydrochloride API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Imipramine Hydrochloride suppliers with KDMF on PharmaCompass.
A Imipramine Hydrochloride CEP of the European Pharmacopoeia monograph is often referred to as a Imipramine Hydrochloride Certificate of Suitability (COS). The purpose of a Imipramine Hydrochloride CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Imipramine Hydrochloride EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Imipramine Hydrochloride to their clients by showing that a Imipramine Hydrochloride CEP has been issued for it. The manufacturer submits a Imipramine Hydrochloride CEP (COS) as part of the market authorization procedure, and it takes on the role of a Imipramine Hydrochloride CEP holder for the record. Additionally, the data presented in the Imipramine Hydrochloride CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Imipramine Hydrochloride DMF.
A Imipramine Hydrochloride CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Imipramine Hydrochloride CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Imipramine Hydrochloride suppliers with CEP (COS) on PharmaCompass.
A Imipramine Hydrochloride written confirmation (Imipramine Hydrochloride WC) is an official document issued by a regulatory agency to a Imipramine Hydrochloride manufacturer, verifying that the manufacturing facility of a Imipramine Hydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Imipramine Hydrochloride APIs or Imipramine Hydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Imipramine Hydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of Imipramine Hydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Imipramine Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Imipramine Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Imipramine Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Imipramine Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Imipramine Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Imipramine Hydrochloride suppliers with NDC on PharmaCompass.
Imipramine Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Imipramine Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Imipramine Hydrochloride GMP manufacturer or Imipramine Hydrochloride GMP API supplier for your needs.
A Imipramine Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Imipramine Hydrochloride's compliance with Imipramine Hydrochloride specifications and serves as a tool for batch-level quality control.
Imipramine Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Imipramine Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Imipramine Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Imipramine Hydrochloride EP), Imipramine Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Imipramine Hydrochloride USP).
LOOKING FOR A SUPPLIER?